Contributors
ROBERT B. ABRAMOVITCH • Department of Microbiology and Molecular Genetics, Michigan
State University, East Lansing, MI, USA
LINDA ADAMS • United States Department of Health and Human Services, Health Resources
and Services Administration, Healthcare Systems Bureau, National Hansen’s Disease
Program, Baton Rouge, LA, USA
RAJENDRA K. AGRAWAL • Division of Translational Medicine, Wadsworth Center, New York
State Department of Health, Albany, NY, USA; Department of Biomedical Sciences,
University at Albany, Albany, NY, USA
JOSE ´ A. AI ´ NSA • Grupo de Gene ´tica de Micobacterias, Departamento de Microbiologı ´a,
Pediatrı ´a, Radiologı ´a y Salud Pu ´ blica, Facultad de Medicina, BIFI Universidad de
Zaragoza-IIS Arag on, Zaragoza, Spain; CIBER Enfermedades Respiratorias
(CIBERES), Instituto de Salud Carlos III, Madrid, Spain
BREE B. ALDRIDGE • Department of Molecular Biology and Microbiology and Stuart B. Levy
Center for Integrated Management of Antimicrobial Resistance, Tufts University School of
Medicine, Boston, MA, USA; Laboratory of Systems Pharmacology, Harvard Medical
School, Boston, MA, USA; Department of Biomedical Engineering and Laboratory for
Living Devices, Tufts University School of Engineering, Medford, MA, USA
ANITA G. AMIN • Mycobacteria Research Laboratories, Department of Microbiology,
Immunology & Pathology, Colorado State University, Fort Collins, CO, USA
NICHOLAS BANAHENE • Department of Chemistry and Biochemistry, Central Michigan
University, Mount Pleasant, MI, USA
IME ` NE BELHAOUANE • Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille,
Center for Infection and Immunity of Lille (CIIL), Lille Cedex, France
HELENA I. M. BOSHOFF • Tuberculosis Research Section, Laboratory of Clinical Immunology
and Microbiology, National Institute of Allergy and Infectious Diseases, National
Institutes of Health, Bethesda, MD, USA
CRISTINA BOSMANI • Department of Biochemistry, Faculty of Science, University of Geneva,
Geneva, Switzerland
REBECCA BRADFORD • ATCC/BEI Resources, Manassas, VA, USA
PRISCILLE BRODIN • Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, Center
for Infection and Immunity of Lille (CIIL), Lille Cedex, France
AMANDA CLAIRE BROWN • Texas A&M Veterinary Medical Diagnostic Laboratory
(TVDML), College Station, TX, USA; Department of Animal Science, Texas A&M
University, Kleberg Center, College Station, TX, USA; Oxford Gene Technology, Oxford,
UK
BRYAN D. BRYSON • Department of Biological Engineering, Massachusetts Institute of
Technology, Cambridge, MA, USA; Ragon Institute of MGH, MIT, and Harvard,
Cambridge, MA, USA
DAIRE CANTILLON • Department of Global Health and Infection, Brighton and Sussex
Medical School, University of Sussex, Brighton, UK
DELPHI CHATTERJEE • Mycobacteria Research Laboratories, Department of Microbiology,
Immunology & Pathology, Colorado State University, Fort Collins, CO, USA
xi
ROBERT B. ABRAMOVITCH • Department of Microbiology and Molecular Genetics, Michigan
State University, East Lansing, MI, USA
LINDA ADAMS • United States Department of Health and Human Services, Health Resources
and Services Administration, Healthcare Systems Bureau, National Hansen’s Disease
Program, Baton Rouge, LA, USA
RAJENDRA K. AGRAWAL • Division of Translational Medicine, Wadsworth Center, New York
State Department of Health, Albany, NY, USA; Department of Biomedical Sciences,
University at Albany, Albany, NY, USA
JOSE ´ A. AI ´ NSA • Grupo de Gene ´tica de Micobacterias, Departamento de Microbiologı ´a,
Pediatrı ´a, Radiologı ´a y Salud Pu ´ blica, Facultad de Medicina, BIFI Universidad de
Zaragoza-IIS Arag on, Zaragoza, Spain; CIBER Enfermedades Respiratorias
(CIBERES), Instituto de Salud Carlos III, Madrid, Spain
BREE B. ALDRIDGE • Department of Molecular Biology and Microbiology and Stuart B. Levy
Center for Integrated Management of Antimicrobial Resistance, Tufts University School of
Medicine, Boston, MA, USA; Laboratory of Systems Pharmacology, Harvard Medical
School, Boston, MA, USA; Department of Biomedical Engineering and Laboratory for
Living Devices, Tufts University School of Engineering, Medford, MA, USA
ANITA G. AMIN • Mycobacteria Research Laboratories, Department of Microbiology,
Immunology & Pathology, Colorado State University, Fort Collins, CO, USA
NICHOLAS BANAHENE • Department of Chemistry and Biochemistry, Central Michigan
University, Mount Pleasant, MI, USA
IME ` NE BELHAOUANE • Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille,
Center for Infection and Immunity of Lille (CIIL), Lille Cedex, France
HELENA I. M. BOSHOFF • Tuberculosis Research Section, Laboratory of Clinical Immunology
and Microbiology, National Institute of Allergy and Infectious Diseases, National
Institutes of Health, Bethesda, MD, USA
CRISTINA BOSMANI • Department of Biochemistry, Faculty of Science, University of Geneva,
Geneva, Switzerland
REBECCA BRADFORD • ATCC/BEI Resources, Manassas, VA, USA
PRISCILLE BRODIN • Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, Center
for Infection and Immunity of Lille (CIIL), Lille Cedex, France
AMANDA CLAIRE BROWN • Texas A&M Veterinary Medical Diagnostic Laboratory
(TVDML), College Station, TX, USA; Department of Animal Science, Texas A&M
University, Kleberg Center, College Station, TX, USA; Oxford Gene Technology, Oxford,
UK
BRYAN D. BRYSON • Department of Biological Engineering, Massachusetts Institute of
Technology, Cambridge, MA, USA; Ragon Institute of MGH, MIT, and Harvard,
Cambridge, MA, USA
DAIRE CANTILLON • Department of Global Health and Infection, Brighton and Sussex
Medical School, University of Sussex, Brighton, UK
DELPHI CHATTERJEE • Mycobacteria Research Laboratories, Department of Microbiology,
Immunology & Pathology, Colorado State University, Fort Collins, CO, USA
xi